CClinicalTrials.gg
Status unknownNCT01672931Updated Aug 27, 2012

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

An observational study in Infertility and Obesity, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2012-08-27.

Sponsored by Hillel Yaffe Medical Center · Observational

The sponsor has not verified this record recently (last verified Aug 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.

02

Conditions studied

  • Infertility
  • Obesity

Browse trials for

03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 60 is below the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Women undergoing IVF treatments

Inclusion criteria

  • IVF treated patients
  • BMI between 20-25 or over 30

Exclusion criteria

Exclusion Criteria:

  • Everyone else
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
60 participants (estimated)

Groups and cohorts

  • BMI over 30

    Women undergoing IVF with BMI over 30

    Other: Oocyte Measurement

  • BMI 20-25

    Women undergoing IVF treatments with BMI between 20-25

    Other: Oocyte Measurement

Interventions

  • OtherOocyte Measurement
06

What researchers measure

Primary outcomes

  1. Larger Size of Oocyte Diameter

    Oocyte will be measured in women undergoing IVF treatment

    Time frame: One year

07

Study locations

1 site
  • Hillel Yaffe Medical Center
    Hadera, 38100, Israel
08

References and documents

Publications

  • Atzmon Y, Shoshan-Karchovsky E, Michaeli M, Aslih N, Shrem G, Ellenbogen A, Shalom-Paz E. Obesity results with smaller oocyte in in vitro fertilization/intracytoplasmic sperm injection cycles-a prospective study. J Assist Reprod Genet. 2017 Sep;34(9):1145-1151. doi: 10.1007/s10815-017-0975-6. Epub 2017 Jun 17. PubMed 28624860 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01672931
Lead sponsor
Hillel Yaffe Medical Center
Responsible party
Sponsor
First posted
Aug 27, 2012
Start date
Sep 2012
Primary completion
Sep 2013 (estimated)
Completion
Sep 2013 (estimated)
Last update
Aug 27, 2012

Study contacts

Gai Shrem, MD
Contact
gai.shrem@gmail.com
972-50-6793080
Gai Shrem, MD
principal investigator · Hillel Yaffe Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion